Glaxosmithkline On Vaccines

GlaxoSmithKline on Vaccines

TBD Media Group

How do we discover new vaccines?

GSK

Ep 2: Getting Ahead Together with... Vaccines

GSK

GSK’s vaccine against RSV wins FDA approval

GSK and Sanofi joining forces to develop a vaccine for COVID-19

GSK

Sanofi, GSK say Covid-19 vaccine won't be ready until late 2021

FRANCE 24 English

COVID-19: GlaxoSmithKline, CureVac to develop vaccine against coronavirus variants

CNA

Covid vaccine by Sanofi-GSK delayed after disappointing results in older patients

CNBC International News

FDA advisory panel votes in favor of adult RSV vaccine from GSK PLC

CNBC Television

GSK on $2.1B vaccine supply deal with U.S.

CNBC Television

GSK beats on top and bottom lines after strong launch of RSV vaccine

CNBC Television

Sanofi, GlaxoSmithKline reach $2.1 billion deal with U.S. to supply vaccine doses

CNBC Television

GSK’s Race to Bring an RSV Vaccine to Market: CNBC Healthy Returns Summit 2023

Glaxo Joins Forces With Sanofi to Develop Coronavirus Vaccine

Bloomberg Television

Coronavirus: VIR CEO on partnering with GSK to develop treatments, vaccines

CNBC Television

GSK bets big on vaccines

NDTV Profit Markets

The GSK RSV Vaccine is Here. Here's What It Means for You | Catalyst Clips

Catalyst Pharmacy Podcast

GlaxoSmithKline and CureVac to collaborate on a new coronavirus vaccine to target multiple strains

Doctor Bharat Pankhania

GlaxoSmithKline CEO Worried Some May Not Take Covid Vaccine

David Rubenstein

GSK Expects Vaccine Approval in First Half of 2021

Bloomberg Television